{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:04:56Z","timestamp":1789643096180,"version":"4.0.0"},"reference-count":4,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jaad.2026.05.105","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:15:00Z","timestamp":1780503300000},"page":"e367-e368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Toward a more nuanced approach: Unaddressed clinical considerations for hydroxychloroquine use in isolated discoid lupus erythematosus"],"prefix":"10.1016","volume":"95","author":[{"given":"Ao","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2026.05.105_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2026.04.022","article-title":"Hydroxychloroquine use and 5-year cardiometabolic profile and cardiovascular risk in isolated discoid lupus erythematosus: a retrospective cohort study","author":"Srikumar","year":"2026","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2026.05.105_bib2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jamadermatol.2024.4991","article-title":"Incidence and prevalence of atherosclerotic cardiovascular disease in cutaneous lupus erythematosus","volume":"161","author":"Chen","year":"2025","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2026.05.105_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2023-000908","article-title":"State of current management of the heightened risk for atherosclerotic cardiovascular events in an established cohort of patients with lupus erythematosus","volume":"10","author":"Zhao","year":"2023","journal-title":"Lupus Sci Med"},{"issue":"6","key":"10.1016\/j.jaad.2026.05.105_bib4","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/art.41683","article-title":"American College of Rheumatology, American Academy of Dermatology, Rheumatologic Dermatology Society, and American Academy of Ophthalmology 2020 joint statement on hydroxychloroquine use with respect to retinal toxicity","volume":"73","author":"Rosenbaum","year":"2021","journal-title":"Arthritis Rheumatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226028082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226028082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T10:57:50Z","timestamp":1789642670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962226028082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":4,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0190962226028082"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2026.05.105","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toward a more nuanced approach: Unaddressed clinical considerations for hydroxychloroquine use in isolated discoid lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2026.05.105","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2026.05.106","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}